APPLICATION
ANDA065190
TYPE
ANDA
ORIGINAL APPROVAL
2004-10-18
LATEST ACTION
2020-03-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CEFUROXIME AXETILDiscontinued
CEFUROXIME AXETIL EQ 500MG BASE · TABLET · ORAL
CEFUROXIME AXETILDiscontinued
CEFUROXIME AXETIL EQ 250MG BASE · TABLET · ORAL
Approval history
2020-03-19Labeling · Supplement 5 · standardAP
2020-03-19Labeling · Supplement 6 · standardAP
2007-10-31Labeling · Supplement 3AP
2004-10-18OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.